InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 06/05/2017

Re: None

Tuesday, 09/19/2017 4:19:21 PM

Tuesday, September 19, 2017 4:19:21 PM

Post# of 9941
The company will need the expertise of professionals outside of the company as it reaches certain development milestones. Growth companies assemble building blocks as they execute on their business model. This appears to be what InMed is doing.

I am glad they are getting the needed expertise from seasoned professionals with distinguished careers at industry giants such as Eli Lilly & Company. It is important to note that Martin Bott, an InMed director, is also VP of Corporate Finance and Investment Banking at Eli Lilly & Company. InMed seems to be building a solid foundation block by block.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News